People · Operator
Named in public records as an officer, director or promoter · active 2012–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pyramid Biosciences, Inc. | — | Biotechnology | Series B | $52.0M | $778.5M | 2016 |
| Mnemosyne Pharmaceuticals Inc | — | Biotechnology | Series A | $24.0M | $445.8M | 2012 |
Kollol Pal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kollol Pal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 1 | 18 |
| Daniel Behr | 1 | 4 |
| William Koster | 1 | 3 |
| John Childs | 1 | 3 |
| Vladimir Coric | 1 | 2 |
| James Bristol | 1 | 2 |
| Larry Feinberg | 1 | 2 |
| Richard Horan | 1 | 2 |
| Jordan Leef | 1 | 1 |
| Frank Menniti | 1 | 1 |
| Vanessa King | 1 | 1 |
| Jessica Barnes | 1 | 1 |
| Jared Fertman | 1 | 1 |
| Benjamin Bronstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.